Plain-English translation of NCT06390371 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 Diabetes Mellitus research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new tool called Spotlight AQ, an artificial intelligence-powered survey that asks you personalized questions about your diabetes before your clinic visits. The goal is to see if using this survey helps lower your blood sugar levels and whether both patients and doctors find it helpful and easy to use.
Many young adults with type 1 diabetes struggle to prepare for their clinic visits and may not bring up all their concerns. This trial exists to see if a personalized survey tool can help identify what matters most to each patient and lead to better conversations with their healthcare team.
You would use the Spotlight AQ survey before attending two of your regular diabetes clinic visits. Before each visit, you would spend time answering the survey's personalized questions about your health and concerns. You would also fill out brief surveys telling the researchers what you thought about using the tool, and you may be invited to participate in a short interview to share your feedback.
AI-generated summary from trial data · Jul 14, 2026 · Not medical advice
United States